A detailed history of Auxier Asset Management transactions in Organon & Co. stock. As of the latest transaction made, Auxier Asset Management holds 37,060 shares of OGN stock, worth $587,401. This represents 0.11% of its overall portfolio holdings.

Number of Shares
37,060
Previous 37,210 0.4%
Holding current value
$587,401
Previous $770,000 8.05%
% of portfolio
0.11%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $2,797 - $3,454
-150 Reduced 0.4%
37,060 $708,000
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $7,468 - $9,398
-428 Reduced 1.14%
37,210 $770,000
Q1 2024

May 08, 2024

SELL
$13.78 - $18.8 $20,242 - $27,617
-1,469 Reduced 3.76%
37,638 $707,000
Q4 2023

Feb 22, 2024

SELL
$10.95 - $17.32 $91,487 - $144,708
-8,355 Reduced 17.6%
39,107 $563,000
Q3 2023

Nov 21, 2023

SELL
$16.59 - $23.77 $11,729 - $16,805
-707 Reduced 1.47%
47,462 $823,000
Q2 2023

Aug 17, 2023

SELL
$19.27 - $24.63 $96 - $123
-5 Reduced 0.01%
48,169 $1 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $1,713 - $2,566
-80 Reduced 0.17%
48,174 $1.13 Million
Q4 2022

Feb 17, 2023

SELL
$23.31 - $28.61 $5,967 - $7,324
-256 Reduced 0.53%
48,254 $1.35 Million
Q3 2022

Nov 15, 2022

BUY
$23.4 - $34.25 $3,744 - $5,480
160 Added 0.33%
48,510 $1.14 Million
Q1 2022

May 17, 2022

SELL
$30.45 - $39.36 $30 - $39
-1 Reduced -0.0%
48,350 $1.69 Million
Q4 2021

Mar 01, 2022

BUY
$28.67 - $37.13 $784,153 - $1.02 Million
27,351 Added 130.24%
48,351 $1.47 Million
Q3 2021

Nov 18, 2021

SELL
$28.63 - $35.64 $1,517 - $1,888
-53 Reduced 0.25%
21,000 $689,000
Q2 2021

Aug 18, 2021

BUY
$28.45 - $38.0 $598,957 - $800,014
21,053 New
21,053 $637,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.03B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Auxier Asset Management Portfolio

Follow Auxier Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.